Enanta Pharmaceuticals
ENTA
#8031
Rank
C$0.53 B
Marketcap
C$18.52
Share price
-0.75%
Change (1 day)
81.87%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of March 2026 : C$0.16 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has C$0.16 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$C$90.1 M-48.29%
2024-09-30$C$0.17 B-40.84%
2023-09-30$C$0.29 B-33.47%
2022-09-30$C$0.44 B-12.61%
2021-09-30$C$0.50 B-16.42%
2020-09-30$C$0.60 B-1.02%
2019-09-30$C$0.61 B21.15%
2018-09-30$C$0.50 B35.08%
2017-09-30$C$0.37 B5.32%
2016-09-30$C$0.35 B12.98%
2015-09-30$C$0.31 B88.79%
2014-09-30$C$0.16 B46.07%
2013-09-30$C$0.11 B163.78%
2012-09-30$C$43.23 M89.98%
2011-09-30$C$22.75 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$113.70 B 69,535.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$54.51 B 33,288.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-C$9.27 Billion-5,771.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$27.11 B 16,507.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$64.32 B 39,296.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$28.15 B 17,142.06%๐Ÿ‡บ๐Ÿ‡ธ USA